Senior Manager, R&D Accounting
Avalo Therapeutics
This listing was originally posted on Avalo Therapeutics's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moAt Avalo (ahh-vah'-low), we are 100% focused on developing treatments for immune-mediated inflammatory diseases with large unmet needs that affect millions worldwide. Our strategy is to develop medicines that target the IL-1β pathway, which is a central driver of the inflammatory process.
We share a commitment to teamwork, passion for science, and dedication to patients suffering from acute and chronic inflammatory disorders. Our collective expertise in discovery, development, and regulatory approvals is evidenced in our strong individual track records of advancing multiple therapeutic programs to successful commercialization.
Position Summary:
Senior Manager, Research & Development (R&D) Accounting to lead the accounting and financial reporting for the Company's research and development activities. Reporting to the Director, Accounting, this individual will be the primary owner of the monthly R&D close process, ensuring the accurate accounting of clinical trial costs, CROs, CMC activities, and other development-related expenditures.
This role partners closely with Clinical Operations, Clinical Development, CMC, FP&A, Program Management, and external vendors to ensure timely, accurate financial reporting while supporting business decision-making. The ideal candidate has deep biotechnology or life sciences R&D accounting experience, strong general ledger expertise, excellent analytical skills, and thrives in a collaborative, fast-paced environment.
Essential Duties and Responsibilities:
Required Education and Experience:
Additional Skills, Knowledge, and/or Responsibilities:
About Avalo Therapeutics
Avalo Therapeutics is a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Our lead asset, abdakibart, is an anti-IL-1β monoclonal antibody (mAb). Positive topline data was recently reported for abdakibart in a Phase 2 clinical trial in hidradenitis suppurativa (HS). In addition to HS, we’re exploring additional opportunities to make an impact in prevalent indications that have significant remaining unmet needs. We are also advancing AVTX-010, a long-acting next-generation anti-IL-1β mAb designed to extend dosing intervals and build upon the differentiated profile established by abdakibart. For more information about Avalo, please visit www.avalotx.com.
ATTENTION: External Agencies and Placement Firms
A member of the Avalo Human Resources Department will contact an agency directly if an open position is eligible to be sourced from an outside recruiting service. Avalo does not accept unsolicited resumes from employment agencies for any employment opportunity. All agencies/recruiters must have a written agreement/SOW in place with Avalo and prior to submitting any resume or CV.
All resumes must be submitted through the appropriate process. Any resumes submitted without an agreement and/or any resumes sent unsolicited through e-mail accounts of Avalo employees will be considered outside of the appropriate process, do not imply or create any obligation on our part, do not impart any restrictions on Avalo with respect to the hiring of any persons whose resumes are so submitted and are not eligible for placement fees.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Avalo Therapeutics?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Small molecules for neuro / psychiatric disorders
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access salary benchmarks and market rate data and other premium pharma intelligence.
Upgrade to Pro — $25/mo